Global Non-Steroidal Anti-Inflammatory Drugs Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Non-Steroidal Anti-Inflammatory Drugs Market Research Report 2024
Non-Steroidal Anti-Inflammatory Drugs are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever,[1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.
According to Mr Accuracy reports’s new survey, global Non-Steroidal Anti-Inflammatory Drugs market is projected to reach US$ 29690 million in 2034, increasing from US$ 20600 million in 2022, with the CAGR of 5.4% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-Steroidal Anti-Inflammatory Drugs market research.
Key companies engaged in the Non-Steroidal Anti-Inflammatory Drugs industry include Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd., Johnson And Johnson Services, Inc. and Merck & Co., Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Non-Steroidal Anti-Inflammatory Drugs were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Non-Steroidal Anti-Inflammatory Drugs market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-Steroidal Anti-Inflammatory Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Pfizer Inc.
Bayer AG
GSK plc
Dr. Reddy’s Laboratories Ltd
Viatris Inc
Teva Pharmaceutical Industries Ltd.
Johnson And Johnson Services, Inc.
Merck & Co., Inc.
Segment by Type
Non-Selective NSAIDs
COX-2 Selective NSAIDs
Dental Pain
Muscle Aches
Pain caused by Gout
Bursitis
Menstrual Cramps
Fever
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Non-Steroidal Anti-Inflammatory Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Non-Steroidal Anti-Inflammatory Drugs market is projected to reach US$ 29690 million in 2034, increasing from US$ 20600 million in 2022, with the CAGR of 5.4% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-Steroidal Anti-Inflammatory Drugs market research.
Key companies engaged in the Non-Steroidal Anti-Inflammatory Drugs industry include Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd., Johnson And Johnson Services, Inc. and Merck & Co., Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Non-Steroidal Anti-Inflammatory Drugs were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Non-Steroidal Anti-Inflammatory Drugs market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-Steroidal Anti-Inflammatory Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer Inc.
Bayer AG
GSK plc
Dr. Reddy’s Laboratories Ltd
Viatris Inc
Teva Pharmaceutical Industries Ltd.
Johnson And Johnson Services, Inc.
Merck & Co., Inc.
Segment by Type
Non-Selective NSAIDs
COX-2 Selective NSAIDs
Segment by Application
Dental Pain
Muscle Aches
Pain caused by Gout
Bursitis
Menstrual Cramps
Fever
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Non-Steroidal Anti-Inflammatory Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices